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ses of flavonoids and alkaloids (Fougerousse et al., 2000;
Ruchirawat and Mutarapat, 2001; Kim et al., 2002) in addition
to the synthesis of potential heterocyclic molecules (Huang
et al., 2005). Moreover, they are widely used in the synthesis
of pharmaceutics, perfumes, flavors, fragrances, dyes, plastics,
antioxidants, stabilizers, fungicides (Naeimi and Moradi,
2005). Interestingly, o-hydroxy acetophenone has been
used in the synthesis of cobalt nanoparticles through the
thermal decomposition of its complex with cobalt metal
(Salavati-Niasari et al., 2009). Basically, o-hydroxy acetophe-Figure 1 Structures of o-
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http://dx.doi.org/10.1016/j.arabjc.2015.09.010nones family covers a lot of examples; however, the most
important members involve phloroacetophenone (Aponte
et al., 2008; Mu¨ller et al., 2010), resacetophenone (Kolla and
Lee, 2011; Chee et al., 2011a) and quinacetophenone
(El-Desoky et al., 2014), as well as visnaginone (El Telbani
et al., 1998; El-Desoky and Al-Shihry, 2008) and kellinone
(Scho¨nberg et al., 1953; Keshk, 2004) which can be found in
a plenty of synthetic methodologies toward potential organic
molecules (Fig. 1).
Quinacetophenone (2,5-dihydroxyacetophenone) 1 repre-
sents an easily accessible o-hydroxyacetophenone derivative
and it has also been used for the synthesis of different potential
organic molecules such as chalcones, flavonoids, chromones,
coumarins, quinones and psoralens (Witiak et al., 1988;hydroxyacetophenones.
ple precursor to privileged organic motifs. Arabian Journal of Chemistry (2015),
Figure 2 Different medicinally active compounds derived from quinacetophenone 1.
Quinacetophenone 3Cushman et al., 1994; Ishizuka et al., 2002; Wellington et al.,
2010). As shown in Fig. 2, different medicinally active com-
pounds have been synthesized from this versatile synthetic pre-
cursor (Cushman et al., 1994; Gerlach et al., 2001; El-Desoky
et al., 2013). Additionally, quinacetophenone 1 has been used
to synthesize various potential synthetic precursors which have
been utilized in the synthesis of novel and complex heterocyclic
compounds (Abdel-Rahman et al., 2005; Ali et al., 2006;
El-Desoky et al., 2014). Encouraged by the aforementioned
utility of o-hydroxyacetophenones, this review presents advan-
tages of quinacetophenone (2,5-dihydroxyacetophenone) 1 as a
simple and available precursor to synthesize diverse and
advantageous organic molecules.
2. Preparation methods
2.1. Friedel–Crafts acetylation
Acetylation can be achieved by treating hydroquinone with
acid chloride or anhydride in the presence of a Lewis acid
(Scheme 1). Rosenmund and Lohfert reported the synthesis
of quinacetophenone 1 through the reaction of hydroquinone
with acetyl chloride in the presence of aluminum chloride
under thermal conditions (Rosenmund and Lohfert, 1928).
On the other hand, acetylation with acetic acid instead of
acetyl chloride or acetic anhydride is an environmentally
benign reaction in which water is the only by-product
(Naeimi and Moradi, 2007). Quinacetophenone 1 was
obtained by the reaction of hydroquinone with acetic acid in
the presence of acidic agents such as borontrifluoride etherate
(BF3OEt2), ferric chloride (FeCl3), zinc chloride (ZnCl2) and
alumina/methanesulfonic acid (Al2O3/CH3SO3H) (Naeimi
and Moradi, 2005). For instance, Hashem and coworkers car-
ried out the acetylation of hydroquinone with acetic acid in the
presence of Al2O3/CH3SO3H in 85% yield (Sharghi and
Kaboudin, 1998).
Zinc powder is used to promote the Friedel–Crafts acetyla-
tion of hydroquinone with acetyl chloride under microwave
irradiation in solvent-free conditions affording quinacetophe-
none 1 in 70% yield. Zn powder can be reused up to six times
after simple washing with diethyl ether and dilute HCl (Paul
et al., 2003). Similarly, the acetylation of hydroquinone usingScheme 1
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conditions gave compound 1 in excellent yield (Gerlach
et al., 2001). Furthermore, the regioselective solvent-free
ortho-acetylation of hydroquinone with acetic acid in the
presence of FeCl3 under microwave irradiation afforded
compound 1 in high yield within short reaction time (Naeimi
and Moradi, 2007).
2.2. Fries rearrangement
Heating hydroquinone diacetate 2 in the presence of Lewis
acids leaded to the formation of quinacetophenone 1
(Scheme 2) (Amin and Shah, 1950; Chen et al., 2004; Qin
et al., 2009). Recently, Boyer and coworkers reported the use
of Al2O3/CH3SO3H as a Lewis acid in the synthesis of quinace-
tophenone 1 from hydroquinone diacetate 2 via Fries rear-
rangement in a very good yield (89%) (Boyer et al., 2000).
Fries rearrangement may proceed via an intramolecular, inter-
molecular or partially intra- and intermolecular mechanisms.
Crossover study showed multiple mechanistic pathways.
Khanna and coworkers reported that the crossover Fries rear-
rangement of hydroquinone diacetate 2 in the presence of
hydroquinone afforded quinacetophenone 1 via treatment with
BF3OEt2 in benzene (Khanna et al., 1992). Furthermore, the
crossover rearrangement proceeded by the treatment of hydro-
quinone diacetate 2 with different phenols such as phenol,
phloroglucinol, 1-naphthol and 2-naphthol (Thapliyal and
Aggarwal, 2000).
A long reflux time and excess amount of a Lewis acid are
needed in order to synthesize quinacetophenone 1 via Fries
rearrangement of hydroquinone diacetate 2. Therefore, the
development of new catalysts is required for promoting the
rearrangement in a clean and regioselective manner. AlCl3–
ZnCl2 mixture supported on silica gel is an efficient catalyst
which promotes the rearrangement under microwave heating
conditions giving compound 1 in (90%) yield (Moghaddam
et al., 1999).
2.3. Hoesch reaction
Quinacetophenone was also prepared via Hoesch reaction
of hydroquinone with acetonitrile in the presence ofScheme 2
ple precursor to privileged organic motifs. Arabian Journal of Chemistry (2015),
Scheme 3
4 E.-S.I. El-Desoky et al.trifluoromethanesulfonic acid followed by hydrolysis of the
reaction mixture (Booth and Noori, 1980).
2.4. From benzoquinone
Klinger and Kolvenbach reported the synthesis of
quinacetophenone 1 via a photochemical reaction between
benzoquinone and acetaldehyde in a fairly good yield as shown
in Scheme 3 (Klinger and Kolvenbach, 1898). Additionally,
Kraus and coworkers carried out the reaction of benzoquinone
with in situ generated acetyl radical, from pyruvic acid through
the reaction with ammonium persulphate, to give quinace-
tophenone 1 in excellent yield (Scheme 3) (Kraus and
Melekhov, 1998).
On the other hand, the Diels–Alder adduct 3, resulted from
the reaction between 2-acetyl-1,4-benzoquinone and cyclopen-
tadiene, underwent a retro reaction at 120 C affording
quinacetophenone 1 (Scheme 3) (Cooper and Sammes, 1980).
Moreover, the target compound 1 can be constructed by other
methods such as hydroxylation of acetophenone (Lindemann
and Romanoff, 1929; Doppler et al., 1979; Kloetzel et al.,
1955; Bruce and Roshan-Ali, 1981; Gesson et al., 1983;
Konieczny et al., 2005; Lamba et al., 2006).
3. Reactions
3.1. Hydroxyl moiety based reactions
3.1.1. Alkylation
The mono- or di-o-alkyl derivatives 4 were obtained when
quinacetophenone 1 was allowed to react with different alkylFigure 3 Mono- and di-O-alkyl derivatives 4a,b.
Scheme
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others under basic conditions (Fig. 3) (Buckle et al., 1979;
Bruce and Roshan-Ali, 1981; Srimal and Kar, 1983; Sircar
et al., 1983; Hellwinkel and Bohnet, 1987; Wymann et al.,
1988; Eggler et al., 1990; DeShong et al., 1991; Erickson
et al., 1992; Wissner et al., 1992; Arvanitis et al., 1996;
Fisher et al., 1998; Cecchi et al., 1999; Lim et al., 2001;
Ishizuka et al., 2002; Roma et al., 2003, 2007; Kiyama et al.,
2003; Koskelainen et al., 2004; Mmutlane et al., 2004;
Summa et al., 2004; Doble et al., 2005; Lal et al., 2010;
Casellas et al., 2006; Dong et al., 2006; Mays et al., 2010;
Zbancioc et al., 2014).
As shown in Scheme 4, the non-hydrogen bonded, less
crowded hydroxyl group of quinacetophenone 1 can be methy-
lated regioselectively by the reaction with Me2CO3 in the pres-
ence of potassium carbonate yielding 2-hydroxy-5-
methoxyacetophenone 5 in moderate yield (Chen et al.,
2004). Similarly, the same hydroxyl group of compound 1
can be capped as silyl ether by the reaction with
tert-butyldimethylsilyl chloride (TBDMS-Cl) in the presence
of 1H-imidazole in excellent yield (Scheme 4) (Aggarwal
et al., 2005).
Moreover, the reaction of quinacetophenone 1 with 2,3,4,6-
tetra-O-acetyl-a-D-galactopyranose 7 via two different meth-
ods (Fischer and Koenigs–Knorr) yielded 2-hydroxy-5-O-
(2,3,4,6-tetra-O-acetyl-b-D-2-galactopyranosyloxy)acetophe
none 8. The deprotection of compound 8 was accomplished by
sodium methoxide producing 2-hydroxy-5-(b-D-2-galactopyra
nosyloxy)acetophenone 9 (Scheme 5) (Konishi et al., 1983).
Quinacetophenone 1 could also be transformed into
mono- or di-(tetrahydropyranyl) ethers 10 or 11 by reaction
with 3,4-dihydro-2H-pyran in the presence of pyridinium
p-toluenesulfonate (Fig. 4) (Fillaut et al., 2008; Cheng et al.,
2008; Mutai et al., 2015). Furthermore, 2-hydroxy-5-
perfluoroalkoxy acetophenone 12 was synthesized by the
reaction of 1 with 1H, 1H, 2H, 2H-perfluoro-1-decane triflate
under basic medium and it is a dye stabilizer having high
quenching efficiency and stability in halogenated solvents. This
dye stabilizer improved the dye fastness in hostile thermal and/
or photooxidation conditions (Fig. 4) (Feng et al., 2004).
The reaction of quinacetophenone with allyl bromide in the
presence of potassium carbonate afforded the corresponding
O-Allylated derivative 13 in excellent yield. Under thermal
reaction conditions, compound 13 underwent Claisen4
ple precursor to privileged organic motifs. Arabian Journal of Chemistry (2015),
Quinacetophenone 5rearrangement yielding 3,6-dihydroxy-2-allylacetophenone 14
in good yield (Scheme 6) (Pillay et al., 2012).
3.1.2. Acylation
Quinacetophenone 1 can be acylated with different alkyl,
cycloalkyl, aryl and heteroaryl acid chlorides in basic medium
affording the corresponding diacylated products 15a–w
(Fig. 5) (Russell and Clark, 1939; Erickson et al., 1992;Scheme
Figure 4 Alkylation
Scheme
Figure 5 Acylation
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2002; Vasquez-Martinez et al., 2007; Jayashree et al., 2010).
In addition, treatment of compound 1 with tert-butyl dicar-
bonate afforded diacylated derivative 15x (R = (CH3)3CO)
in 82% yield (Jones et al., 2001). Similarly, Baker reported that
the acetylation of 1 by using acetic anhydride and anhydrous
sodium acetate afforded 2-hydroxy-5-acetoxyacetophenone
16 (Fig. 5) (Baker, 1934).5
derivatives 10–12.
6
derivatives 15–18.
ple precursor to privileged organic motifs. Arabian Journal of Chemistry (2015),
6 E.-S.I. El-Desoky et al.On the other hand, Candida Antarctica Lipase B (CAL-B)
was found to be a highly active biocatalyst for the direct acy-
lation of compound 1 with vinyl acetate and propanoate as
acyl donors affording compounds 16, 17 and 18 (Fig. 5)
(Nicolosi et al., 1993; Miyazawa et al., 2008). Additionally,
Rajakumar and coworkers reported the synthesis of
cyclophane diamide 20 by the reaction of quinacetophenone
1 with N,N0-(a,a0dichloroacetyl)-1,2-phenylenediamine 19
(Scheme 7) (Rajakumar et al., 2006).
3.2. Active methylene moiety based reactions
3.2.1. Mannich reaction
Agarwal and coworkers reported that quinacetophenone 1
underwent Mannich reaction with aniline and benzidine toScheme
Figure 6 Mannich
Scheme
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tively (Fig. 6) (Agarwal and Saxena, 1980).
3.2.2. Claisen–Schmidt reaction
2-Hydroxychalcones are considered as very economically
precursors for construction of the highly medicinally active fla-
vones and related motifs. Also, most of 2,5-dihydroxychalcone
derivatives showed excellent antiinflammatory activity due to
their potent inhibitory effects on the release of chemical
mediators from inflammatory cells (Ko et al., 2003). These
interesting motifs can be obtained by Claisen–Schmidt conden-
sation of quinacetophenone 1 with a series of aromatic and
heteroaryl aldehydes (Vyas and Shah, 1949; Bruce et al.,
1953; Fujise et al., 1954; Hsieh et al., 1998; Ko et al., 2003;
Nam et al., 2003; Won et al., 2005; Moorthy et al., 2006;7
bases 21 and 22.
8
ple precursor to privileged organic motifs. Arabian Journal of Chemistry (2015),
Quinacetophenone 7Singh et al., 2010; Avupati et al., 2012; Kupcewicz et al., 2014;
Ravichandran et al., 2014). The condensation of protected
quinacetophenone 1 with aldehydes afforded various hydroxylScheme
Scheme 1
Scheme 1
Scheme 1
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dihydroxychalcones 24(1–29) by deprotection in the presence
of p-toluenesulfonic acid (Scheme 8). The produced chalcones9
0
1
2
ple precursor to privileged organic motifs. Arabian Journal of Chemistry (2015),
Scheme 13
8 E.-S.I. El-Desoky et al.24(1–29) showed excellent antiinflammatory and antitumor
activities (Hsieh et al., 1998; Ko et al., 2003; Nam et al., 2003).
As shown in Scheme 9, other protecting groups can be
utilized instead of tetrahydropyranyl groups during the forma-
tion of chalcones. The reaction of the benzyl protected
quinacetophenone 25a with the benzyl protected salicaldehyde
26 in 40% aqueous solution of KOH afforded the correspond-
ing protected hydroxychalcone 27. Then, the deprotection of
the benzyl ether 27 was accomplished via treatment with boron
trichloride (BCl3) to afford the targeted hydroxychalcone 28
which showed high in vitro inhibitory activity of b-secretase
(a molecular target for therapeutic intervention in Alzheimer’s
disease) (Ma et al., 2011). Similarly, by using quinacetophe-
none protected as methyl ether 25b, pyrrole containing chal-
cone 30 was synthesized in moderate yield (Rane et al., 2013).
On the other hand, the reaction of 4-nitrobenzaldehyde, 9-
anthraldehyde or acetaldehyde with quinacetophenone 1 in
basic medium failed to give the corresponding chalcones.
Alternatively, these products were obtained by condensation
under acidic medium (Russell and Happoldt, 1942; Bruce
et al., 1953; Nam et al., 2003). Additionally, Won and cowork-
ers reported that 3,5-di-tert-butyl-4-hydroxystyrylhydroquiFigure 7 1-(2,5-Dihydroxyphenyl)-1-oxo-methylbutane-3-ol 41.
Scheme 1
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and 3,5-di-tert-butyl-4-hydroxybenzaldehyde 31 by ultrasonic
agitation on basic alumina (Scheme 10) (Won et al., 2005).
Konishi and coworkers reported the synthesis of 4-(b-D-2-
galactopyranosyloxy)-2-(30-hydroxy-40-methoxycinnamoyl)ph
enol 33 which was reduced with hydrogen in the presence of
Pd–C (10%) catalyst yielding the corresponding dihydrochal-
cone 34 (Scheme 11) (Konishi et al., 1983).
3.2.3. Synthesis of a,c-diketo acid (DKA)
a,c-Diketo acids (DKA) were discovered as selective and rever-
sible inhibitors of hepatitis C virus NS5b RNA-dependent
RNA polymerase. The diketo acid moiety proved to be essen-
tial for this activity, while substitution on the c-position was
necessary for selectivity and potency (Summa et al., 2004).
As shown in Scheme 12, O-alkylation of compound 1 by using
two different alkylating agents 2-cyanobenzyl bromide and
d-bromovaleronitrile in the presence of Cs2CO3, yielded 2-((3
-acetyl-4-(3-cyanopropoxy)phenoxy) methyl)benzonitrile 35.
Compound 35 was reacted with diethyloxalate in NaOEt to
give C-benzoylpyruvic acid derivative 36 (Scheme 12) via
Claisen condensation (Summa et al., 2004).
3.2.4. Synthesis of b-diketone
O-benzylation of 2-hydroxy-5-methoxyacetophenone 37 using
2-methoxycarbonyl benzyl bromide 38 afforded the expected
2-benzyloxy-5-methoxyacetophenone 39 which was cyclized
via Claisen condensation to give 2-methoxydibenzo[b,g]-
oxonine-11,13(6H,12H)-dione 40 (Scheme 13) (Hellwinkel
and Bohnet, 1987).4
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The reaction of 1 with acetone in the presence of lithium
diisopropylamide gave 1-(2,5-dihydroxyphenyl)-1-oxo-methyl-
butane-3-ol 41 (Fig. 7) (Banerji and Goomer, 1984).
3.2.6. Bromination
2-Bromo-hydroxyacetophenones are important intermediates
in the synthesis of various biologically active compounds inScheme 15
Scheme 1
Figure 8 Condensatio
Please cite this article in press as: El-Desoky, E.-S.I. et al., Quinacetophenone: A sim
http://dx.doi.org/10.1016/j.arabjc.2015.09.010addition to their use in the manufacture of simulated pho-
tographic quality print, stabilizers of hydrogen peroxide in
paper industry and other applications. Selective bromination
of quinacetophenone 1 at the active methylene moiety was
accomplished via different routes (Scheme 14). The most
efficient methodology involves the bromination of quinace-
tophenone 1 using bromine in the presence of AlCl3 and
Montmorillonite K10 (Uchil and Joshi, 2003). Additionally,
2,5 dihydroxyphenacyl bromide 42 was synthesized by the
refluxing of 1 with CuBr via ultrasound-assisted bromina-
tion in heterogeneous catalysis as shown in Scheme 14
(Zbancioc et al., 2010). Finally, the same product 42 was
obtained by the microwave irradiation of quinacetophenone
1 in the presence of urea–hydrogen peroxide complex and
sodium bromide over silica gel–acetic acid (Paul et al.,
2005).6
n derivatives 45–55.
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3.3.1. Acetal formation
The reaction of quinacetophenone 1 with ethylene glycol in
the presence of p-toluenesulfonic acid afforded 2-(2-methyl-
1,3-dioxolan-2-yl) benzene-1,4-diol 43 in excellent yield
(Scheme 15) (Beddoes et al., 1981).
3.3.2. Horner–Emmons–Wadsworth reaction
a,b-Unsaturated esters are considered as a good synthons for
different heterocyclic compounds. The reaction of dibenzyl
ether 25a with triethyl phosphonoacetate via Horner–Emmon
s–Wadsworth reaction (HWE reaction) in the presence of
potassium tert-butoxide furnished predominantly ester E-44
(E:Z= 8:1) in excellent yield (Scheme 16) (DeShong et al.,
1991).
3.3.3. Condensation reactions
The condensation of quinacetophenone 1 with hydroxylamine
hydrochloride afforded the corresponding oxime 45 in excel-
lent yield. Moreover, different Schiff bases 46–48 were
obtained by the reaction of 1 with aryl and heteroaryl amines.
Also, the treatment of 1 with hydrazine monohydrate as well
as different hydrazines furnished the corresponding
hydrazones 49–54 (Horii, 1937; Veibel and Schmidt, 1948;
Verma and Verma, 1983; Manrao et al., 1984; Petrov et al.,Scheme 1
Scheme 1
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Nair and Shamla, 2009; Sakamoto and Okuyama, 2014a,
2014b). In addition, the condensation of compound 1 with
semicarbazide hydrochloride afforded the corresponding
semicarbazone 55 in 84% yield (Fig. 8) (Petrov et al., 2006).
3.3.4. Synthesis of oxadiazinanone derivative
Recently, 2-(2,5-dihydroxyphenyl)-2-methyl-1,3,4-oxadiazi
nan-5-one 57 was synthesized by the reaction of quinacetophe-
none 1 and cyanoacetic acid hydrazide 56 in acetic acid
(Scheme 17) (Parveen et al., 2013).3.3.5. Reduction
Depending upon the nature of the reductant, different prod-
ucts 58–60 were obtained by the reduction of quinacetophe-
none 1. Firstly, ethyl hydroquinone 58 was obtained through
the reduction of carbonyl group via different methods (A:
Clemmensen reduction; B: Wolff–Kishner reduction; C: H2/
Pd; D: H2/copper(II) chromite) (Verheggen et al., 2007; Wu
et al., 1987; Kneppe and Schneider, 1983; Vandenberghe and
Willems, 1965). Moreover, a-phenylethanol 59 was produced
by performing the reduction using HCl/sodium cyanoborohy-
dride (Miyamura et al., 2008). On the other hand, the reductive
dimerization of 1 was accomplished in the presence of NaOH/
sodium amalgam to give diphenylbutan-2,3-diol derivative 60
(Scheme 18) (Gie, 1945).7
8
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3.4.1. Synthesis of azoles
The reaction of quinacetophenone 1 with ethyl hydrazinecar-
boxylate followed by the treatment with thionyl chloride
afforded 4-(2,5-dihydroxyphenyl)-1,2,3-thiadiazole 61 in mod-
erate yield (Petrov et al., 2002). Similarly, selenadiazole deriva-
tive 62 was synthesized via the conversion of quinacetophenone
1 into the corresponding diacetylated semicarbazoneScheme 1
Scheme 2
Scheme 2
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et al., 2006). Sanchez-Viesca and coworkers reported the syn-
thesis of 2-methyl-4(2,5-dihydroxyphenyl)thiazole 63 through
the bromination of quinacetophenone 1 and subsequent
reaction with thioacetamide (Scheme 19) (Sanchez-Viesca
et al., 2003).
Pyrazole 64 was identified as a specific inhibitor of
N-acetyltransferase enzyme (NAT) which had been implicated
as a potential antitubercular target. This pyrazole 64 was9
0
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12 E.-S.I. El-Desoky et al.synthesized from 2-hydroxy-5-methoxyacetophenone 37 via a
Claisen-type reaction followed by subsequent condensation
with hydrazine (Scheme 20). Guided by in silico molecular
docking studies, other potent antitubercular pyrazoles 65, 66
and 67 were designed, and synthesized via similar manner
(Scheme 20) (Fullam et al., 2013).
3.4.2. Synthesis of indole heterocycle
O-Methylation of quinacetophenone 1 followed by the reac-
tion with phenylhydrazine, subsequent Fischer indolization
and finally demethylation yielded indole derivative 68
(Scheme 21) (Sharma et al., 1983).Scheme 22
Scheme 2
Scheme 2
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3.5.1. Synthesis of chromones
Most of chromones possess a broad range of biological activ-
ities, such as antimycobacterial, antifungal, anticancer, antimi-
crobial and others. These derivatives are also important
intermediates in the manufacture of agrochemicals and
pharmaceuticals (Tu et al., 2013). Acylation of compound
1 followed by Baker–Venkataraman rearrangement
afforded 1,3-diketones 69a–g. Cyclization of the diketones
69a–g in acidic medium followed by hydrolysis afforded
6-hydroxychromones 70a–g (Scheme 22) (Erickson et al.,
1992; Billich et al., 1999; Nussbaumer et al., 2002).
Also, chromones 71 and 72 were synthesized by the reaction
of quinacetophenone 1 with acetic anhydride or diethyl oxalate
under basic conditions (Scheme 23) (Mujica-Fernaud et al.,
2004; Desai and Mavani, 1947).
Park and coworkers utilized quinacetophenone 1 as a start-
ing materials to synthesize 2-arylmethylaminomethyl-5,6-dihy
droxychromone derivatives with selective anti-HCV activity
(Park et al., 2011). Oxidation of 1 with PhI(OAc)2 in MeOH
furnished the corresponding 6-methoxy derivative in 45% yield
followed by protection with benzyl and acetyl groups to pro-
vide the intermediate 73. Intramolecular Claisen condensation
of 73 in the presence of tert-BuOK resulted in the construction
of the chromone 74. Oxidation of the alkyl moiety yielded the
corresponding aldehyde, which underwent reduction followed
by bromination to give 2-bromomethylchromone derivative
75. Compound 75 was treated with different arylmethylamines
followed by deprotection to give the desired 2-arylmethylami
nomethyl-5,6-dihydroxychromone derivatives 76 in 40–80%3
4
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Quinacetophenone 13yield (Scheme 24). The latter synthesized 2-arylmethylamino
methyl-5,6-dihydroxychromone derivatives 76 showed selec-
tive anti-HCV effect with no cytotoxicity up to 100 lM
(Park et al., 2011).
On the other hand, the potent and selective monoa-
mine oxidase B (MAO-B) inhibitors are crucial for the
therapy of neurodegenerative disorders such as Parkinson’sScheme 2
Scheme 2
Scheme 2
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of chromone-3-(carboxaldehyde, carboxylic acid and
carboxylic ester) were synthesized from the versatile
precursor quinacetophenone 1 (Scheme 25). The com-
pounds 79, 80 and 81 are potent and selective MAO-B
inhibitors [IC50 = 0.0028, 0.004, 0.0057 lM] (Legoabe
et al., 2012).5
6
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14 E.-S.I. El-Desoky et al.Via Vilsmeier Haack reaction, the treatment of quinace-
tophenone 1 with POCl3/DMF afforded 6-hydroxy-4H-4-oxo
[l]benzopyran-3-carboxaldehyde 82 which is very powerful
synthon for various heterocyclic compounds such as azoles,Scheme 2
Scheme 2
Scheme 3
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Rahman et al., 2005; Qin et al., 2009; Tu et al., 2013).
Additionally, the treatment of quinacetophenone 1 with
triethyl orthoformate and perchloric acid (70%) followed by8
9
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Quinacetophenone 15
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Quinacetophenone 17aqueous hydrolysis of the intermediate perchlorate salt afforded
the corresponding 6-hydroxy-4H-4-oxo[1]benzopyran 83 in
moderate yield.
3.5.2. Synthesis of chromanones
Refluxing of quinacetophenone 1 with aliphatic aldehydes and
ketones namely acetone, butanone, cyclopentanone, cyclohex-
anone, cycloheptanone, tert-butyl-4-oxopiperidine-1-carboxy-
late, 1-benzyl-4-piperidine, 4-oxo-butyric acid tert-butyl ester,
sulcatone, geranylacetone, nerylacetone, farnesylacetone, phy-
tone (hexahydrofarnesylacetone) and 14-hydroxy-tetradecan-
2-one in the presence of basic catalyst such as pyrrolidine
and piperidine leaded to the synthesis of the corresponding
chromanones 84a–q in excellent yields (Scheme 27) (Yamato
et al., 1981; Kabbe and Widdig, 1982; Mizuguchi et al.,
1993; Pearce et al., 1994; Cascaval et al., 1998; Le et al.,
2008; Letourneau et al., 2005; Tripathi et al., 2009; Lingam
et al., 2010; Coowar et al., 2010; Kallan et al., 2011;
Becknell et al., 2012; Dandu et al., 2012; El-Desoky et al.,
2013). Compared to other secondary amines, pyrrolidine
proved to be the best catalyst for the synthesis of chromanoneScheme 37
Scheme 3
Scheme 3
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manone derivatives 84a–q could not be synthesized in the pres-
ence of sodium hydroxide or tertiary amines catalysts (Yamato
et al., 1981; Kabbe and Widdig, 1982; Mizuguchi et al., 1993;
Pearce et al., 1994; Cascaval et al., 1998; Gerlach et al., 2001;
Le et al., 2008; Tripathi et al., 2009; Lingam et al., 2010;
Coowar et al., 2010). In 2009, microwave was exploited for ini-
tiating the reaction leading to excellent yields of compounds
84a,b,k,l (Tripathi et al., 2009; Lingam et al., 2010).
The reaction mechanism for the formation of 2,2-dialkyl or
spirocycloalkyl (or heterocycloalkyl)chromanones 84a–q was
proposed by Kabbe and Widdig as shown in Scheme 28
(Kabbe and Widdig, 1982). In the first step, the base (pyrro-
lidine) reacts with the aldehyde or ketone to form alkylidene
ammonium ion 85 or enamine 86 forms. Either of them reacts
with quinacetophenone 1 by the effect of base via Michael
addition to yield the Michael adduct 87. Finally, the latter
compound 87 may either undergo nucleophilic displacement
of pyrrolidine by the phenolic moiety affording the target
4-chromanone derivatives 84a–q or eliminate pyrrolidine to
give the enone 88.8
9
Figure 9 2-Acetyl-1,4-benzoquinone 124.
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18 E.-S.I. El-Desoky et al.Unfortunately, 4-(1-pyrrolidinyl)chromenes 89 were formed
during these reactions (usually less than 15%) and this is
explained as shown in Scheme 29 (Kabbe and Widdig, 1982).
3.5.3. Synthesis of flavonoids
Flavonoids are a class of natural products that are known to
have antioxidant activity as well as a wide range of other
pharmacological properties. One of the classical methods
for the preparation of their c-pyrone structure is via the
Baker–Venkataraman rearrangement (Chee et al., 2011b).
Acylation of quinacetophenone 1 with benzoic, anisic and
trimethylgallic anhydrides 90a–c in the presence of sodium salt
of the corresponding acid followed by Baker–Venkataraman
rearrangement and cyclization afforded the corresponding fla-
vones 91a–c (Scheme 30) (Chadha and Venkataraman, 1933).
By heating quinacetophenone 1 with excess benzoyl
chloride in wet K2CO3/acetone, the corresponding flavone 92
was obtained in 51% yield in addition to 3-benzoylflavone
93 in 23% yield. The proposed mechanism for the formation
of flavone 92 and 3-benzoylflavone 93 is shown in Scheme 31
(Chee et al., 2011b).
The generation of lithium enolate from acetyl group of
quinacetophenone 1 was achieved by using lithium bis
(trimethylsilyl)amide (LiHMDS) and then, treatment of these
lithium polyanions with acid chlorides afforded the diketones
100a,b in quantitative yields. Cyclization of these diketonesScheme 4
Scheme 4
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vones 101a,b (Scheme 32) (Cushman et al., 1994). Similarly,
flavone 102 was prepared by using Li(OH)2 as a base under
inert conditions (Scheme 32) (Carola et al., 2004).
The reaction of compound 1 with 5-aldehydosalicylic acid
103/orthoformic acid in the presence of perchloric acid
(70%) followed by hydrolysis afforded the corresponding
flavone 104 (Scheme 33) (Oganesyan et al., 1989).
Additionally, quinacetophenone 1 was utilized in the syn-
thesis of isoflavones 108a–d via the enaminone intermediate
105. After the one pot-two step ring closure and iodination
via addition of I2 in MeOH, the key precursor 3-
iodochromone 106 was produced in good yield. Using a green
approach for the Suzuki reaction, 3-iodochromone 106 was
coupled with phenylboronic acids 107a–d in the presence of
Pd(OAc)2 along with poly(ethylene glycol) 10,000 (PEG
10,000) as the ligand to give isoflavones (3-phenylchromen-4-
ones) 108a–d efficiently (Scheme 34) (Biegasiewicz et al., 2014).
The reaction of quinacetophenone 1 with aromatic aldehy-
des in ethylorthoformate in the presence of perchloric acid
(70%) gave the corresponding 4-ethoxyflavylium perchlorate
derivatives 109a–c (Scheme 35) (Oganesyan et al., 1989; Sato
et al., 1999).
On the other hand, the recent studies have demonstrated
that silybin exerts cytotoxic activity against cancer cell lines;
however the main drawback is that silybin manifests poor0
1
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low bioavailability and poor water solubility. As an attempt to
circumvent these issues, silybin analogues 115 and 116 were
constructed from quinacetophenone 1 as shown in Scheme 36.
After evaluation of the anti-proliferative activity against
SKBR3 (estrogen receptor negative, HER2 over-expressing
breast cancer cells) and MCF-7 (estrogen receptor positive
breast cancer cells) cell lines, silybin analogues 115 and 116
exhibited improved anti-proliferative activity compared to
the natural silybin (Scheme 36) (Zhao et al., 2011a, 2011b).
3.6. Electrophilic substitution reactions
3.6.1. Nitration
The nitration of quinacetophenone 1 with a mixture of HNO3
and CH3CO2H afforded 2,5-dihydroxy-3-nitroacetophenone
117, while only 2,5-dihydroxy-2,6-dinitro acetophenone 118Scheme 4
Scheme 4
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3.6.2. Halogenation
The electrophilic substitution of quinacetophenone 1 by the
reaction with bromine yielded the mono and dibromo deriva-
tives 119 and 120 (Desai et al., 1954). Also, free radical elec-
trophilic substitution reaction of 1 with N-chlorosuccinimide
(NCS) under inert atmosphere afforded 1-(3-chloro-2,5-dihy
droxy)phenylethanone 121 (Scheme 38) (Baker et al., 2011).
3.7. Miscellaneous reactions
3.7.1. Synthesis of phenazine derivative
A facile synthesis of acetylphenazine derivative 123
was accomplished via refluxing of equimolar amounts of
2,5-dihydroxyacetophenone 1 and benzofuroxan 122 in the2
3
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20 E.-S.I. El-Desoky et al.presence of molecular sieves 4 A˚ (Scheme 39) (Takabatake
et al., 2000).
3.7.2. Synthesis of quinone derivatives
Quinacetophenone 1 can be oxidized into the corresponding
2-acetyl-1,4-benzoquinone 124 in a very good yield by a wide
variety of oxidizing agents such as silver oxide, manganese
dioxide, manganese dioxide impregnated with nitric acid, Au
clusters immobilized on a polystyrene based polymer/O2 and
silica gel supported heterogeneous ceric ammonium nitrate
(CAN) (Fig. 9) (Cassis and Valderrama, 1983; Brimble et al.,
2004; Ali et al., 2006; Miyamura et al., 2008).
Additionally, Niedermeyer and coworkers reported a novel
procedure for the oxidation of quinacetophenone 1 into
2-acetylbenzoquinone 124 by using laccase, copper containing
phenol oxidases, catalyzed reactions in the presence of oxygen
(Niedermeyer et al., 2005). Quinone 124 is well known precur-
sor for the synthesis of different biologically active molecules
(Ali et al., 2006).
On the other hand, the natural product marticin that
was produced by Fusarium solani and Fusarium martii,
possesses antibacterial activity against Staphylococcus aureus
(128 lg/mL) and Staphylococcus pyogenes (128 lg/mL). In
2012, Pillay and coworkers reported a methodology to
construct the quinone core structure 131 of marticin starting
from quinacetophenone 1 (Scheme 40) (Mmutlane et al.,
2004; Pillay et al., 2012).
By going to extended quinone structure, the reaction of 1
with phthalic anhydride in the presence of H2SO4 and
H3BO3 afforded 2-acetyl-1,4-dihydroxyanthracene-9,10-dione
132 (Scheme 41) (Willstaedt and Michaelis, 1938).Please cite this article in press as: El-Desoky, E.-S.I. et al., Quinacetophenone: A sim
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The benzofurans functionalized with hydroxyl and acetyl
groups are not only the core structures found in a large
number of biologically important natural products, but also
the vital precursors for several naturally occurring furoflavo-
noids. In addition, benzofuran and dihydrobenzofuran deriva-
tives and their dimers in isolated or rigid conformations are
key structural units found in large number of medicinal plants
(Dixit et al., 2006).
Numerous synthetic methodologies are available in the lit-
erature for the construction of benzofuran ring system due to
its wide-ranging applications. Two isomeric benzofurans,
6-acetyl-5-hydroxybenzofuran 134 and 4-acetyl-5-hydroxyben-
zofuran 135 were synthesized in good yield from commercially
available quinacetophenone 1 through a-phenoxyacetaldehyde
diethylacetal intermediate 133. Heating benzofuran derivativesple precursor to privileged organic motifs. Arabian Journal of Chemistry (2015),
Scheme 46
Quinacetophenone 21134 and 135 in the presence of amberlyst 15 afforded the
benzofuryl benzofuran derivatives 136 and 137, respectively
in good yield (Scheme 42) (Dixit et al., 2006).
Also, the reaction of 1 with p-substituted phenacyl bromide
138 in the presence of K2CO3 furnished the 2-benzoyl-3-
methylbenzofuran derivative 139 in moderate yield (Scheme 43)
(Belanger et al., 1985). Yamaguchi and coworkers reported the
synthesis of 2-vinyl substituted dihydrobenzofuran derivatives
141 and 142 by the reaction of quinacetophenone 1 with
1,4-dibromo-2-methyl-2-butane 140 in the presence of sodium
hydride (Scheme 43) (Yamaguchi et al., 1986).
Additionally, a series of 2-benzylidene-benzo[b]furan-3-
ones (aurones) 147 were designed depending upon docking
studies to be screened as inhibitors for preadipocyte prolifera-
tion and differentiation. The synthetic strategy depends upon
the mono methoxymethylation of 1 and subsequent formation
of the corresponding chalcones 144. Then, aurones 145 were
obtained via the oxidative cyclization methodology using mer-
cury acetate in pyridine as Z-geometry. Finally, the deprotec-
tion of the MOM group was followed by acylation with in situ
prepared fatty acid chloride affording the corresponding aur-
one esters 147 (Scheme 44). After evaluating the activity of
the synthesized aurones 147, different compounds could effi-
ciently inhibit preadipocyte proliferation and adipogenesis in
comparison with Oleoyl Formononetin (OF) in addition to
enhancement of glucose consumption in the cells (Zhao
et al., 2011a, 2011b).
3.7.4. Synthesis of coumarins
There are many synthetic routes to construct coumarins
including Pechmann, Perkin, Knoevenagel, Reformatsky and
Wittig reactions (De and Gibbs, 2005). As shown in Scheme 45,
the reaction of quinacetophenone 1 with phenylacetyl chloride
in the presence of potassium carbonate furnished 6-hydroxy-4-
methyl-3-phenylcoumarin 148 (Neelakantan et al., 1982). As
also depicted in Scheme 45, Brubaker and coworkers reported
that the reaction between quinacetophenone 1 and [(ethoxycar
bonyl)-methylene]triphenylphosphone (Ph3P = CHCOOC2H5)Please cite this article in press as: El-Desoky, E.-S.I. et al., Quinacetophenone: A sim
http://dx.doi.org/10.1016/j.arabjc.2015.09.010afforded 6-hydroxy-4-methyl-2H-1-benzopyran-2-one 149
(Brubaker et al., 1986).
In 2002, Bandgar and coworkers reported that
under microwave irradiation a mixture of 1 and Meldrum’s
acid in the presence of lithium perchlorate afforded
6-hydroxycoumarin-3-carboxylic acid 150 in a very good yield
(Scheme 46) (Bandgar et al., 2002). Additionally, Salama and
coworkers developed a simple, mild and efficient protocol for
the one-pot synthesis of coumarin-3-carbonitriles 151 via a
typical Knoevenagel condensation of 1 and malononitrile in
86% yield using SiCl4 as dehydrating agent (Scheme 46)
(Salama et al., 2012).
4. Conclusion
Quinacetophenone is one of the most important
o-hydroxyacetophenones which represents an useful precursor
in both organic and medicinal chemistry. This versatile precur-
sor can be easily synthesized via different methods such as
Friedel–Crafts acetylation and Fries rearrangement. Based
upon its chemical moieties, various chemical transformations
have been designed. As a result, quinacetophenone has been
used for the synthesis of various naturally and biologically
active compounds.
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